Consolidated Condensed Statements of Operations (Unaudited) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2011	Sep. 30, 2010
Net Revenues:
Services	$ 3,287,272	$ 3,530,002	$ 9,388,267	$ 11,725,974
Product sales	1,195,700	1,345,443	3,707,840	4,001,161
Total revenues	4,482,972	4,875,445	13,096,107	15,727,135
Cost of Services and Sales:
Cost of services	1,299,030	1,349,730	3,814,933	4,206,611
Cost of sales	462,048	426,533	1,259,404	1,121,699
Total cost of services and sales	1,761,078	1,776,263	5,074,337	5,328,310
Gross Margin	2,721,894	3,099,182	8,021,770	10,398,825
Operating Expenses:
Selling, general and administrative	3,316,295	3,746,016	10,039,289	11,891,477
Bad debt expense	387,388	374,689	628,215	1,155,583
Impairment of fixed assets		762,224		762,224
Depreciation and amortization	279,463	318,503	836,936	984,326
Total operating expenses	3,983,146	5,201,432	11,504,440	14,793,610
Other (Expense):
Interest expense, net	(300,791)	(342,345)	(975,735)	(913,031)
Other expense	(3,000)		(12,234)	(2,487)
Net other (expense)	(303,791)	(342,345)	(987,969)	(915,518)
Income (loss) from continuing operations, before taxes	(1,565,043)	(2,444,595)	(4,470,639)	(5,310,303)
(Provision) benefit for income taxes	(3,498)	(3,498)	(10,494)	(4,502)
Income (loss) from continuing operations, net of taxes	(1,568,541)	(2,448,093)	(4,481,133)	(5,314,805)
Income (loss) from discontinued operations, net of taxes	(14,896)	(1,382,911)	376,478	(115,184)
Net income (loss)	(1,583,437)	(3,831,004)	(4,104,655)	(5,429,989)
Less: Net income (loss) attributable to noncontrolling interests	(27,544)	(61,233)	(130,626)	(95,961)
Net income (loss) attributable to Graymark Healthcare	$ (1,555,893)	$ (3,769,771)	$ (3,974,029)	$ (5,334,028)
Earnings per common share (basic and diluted):
Net income (loss) from continuing operations	$ (0.10)	$ (0.33)	$ (0.42)	$ (0.72)
Income from discontinued operations		$ (0.19)	$ 0.04	$ (0.02)
Net income (loss) per share	$ (0.10)	$ (0.52)	$ (0.38)	$ (0.74)
Weighted average number of common shares outstanding	14,885,911	7,244,516	10,332,069	7,247,826
Weighted average number of diluted shares outstanding	14,885,911	7,244,516	10,332,069	7,247,826